DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Bleomycin (Bleomycin) - Side Effect Reports to FDA

 
 



This is an index of side effect / adverse reaction reports (a.k.a. adverse event reports) related to Bleomycin and submitted to the FDA during the sample period of about a year. The information is not vetted and should not be considered as verified clinical evidence.

Reports by Event Outcome

All Cases (37)
Death (8)
Disability (8)

Reports by Reaction Type

Respiratory Disorder (8)Pulmonary Toxicity (5)Pancytopenia (5)Gastrointestinal Haemorrhage (3)Pyrexia (3)Blood Creatinine Increased (3)Bronchopulmonary Aspergillosis (2)Histiocytosis Haematophagic (2)Vomiting (2)Nausea (2)Diffuse Large B-Cell Lymphoma Recurrent (2)Maternal Exposure Timing Unspecified (2)

Below are a few examples of reports where side effects / adverse reactions may be related to Bleomycin. For a complete list or a specific selection of reports, please use the links above.

Possible Bleomycin side effects in 29 year old female

Reported by a physician from Hungary on 2012-08-27

Patient: 29 year old female

Reactions: Histiocytosis Haematophagic, Cytomegalovirus Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Bleomycin
    Dosage: 8 cycles
    Indication: Hodgkin's Disease
    Start date: 2006-01-01

Carboplatin
    Dosage: 2 cycles
    Indication: Hodgkin's Disease
    Start date: 2006-01-01

Cisplatin
    Dosage: 2 cycles
    Indication: Hodgkin's Disease
    Start date: 2006-01-01

Cytarabine
    Dosage: 2 cycles
    Indication: Hodgkin's Disease
    Start date: 2006-01-01

Dacarbazine
    Dosage: 8 cycles
    Indication: Hodgkin's Disease
    Start date: 2006-01-01

Dexamethasone Sodium Phosphate
    Dosage: 2 cycles
    Indication: Hodgkin's Disease
    Start date: 2006-01-01

Doxorubicin HCL
    Dosage: 8 cycles
    Indication: Hodgkin's Disease
    Start date: 2006-01-01

Doxorubicin HCL
    Dosage: unk
    Indication: Hodgkin's Disease

Etoposide
    Dosage: 2 cycles
    Indication: Hodgkin's Disease
    Start date: 2006-01-01

Etoposide
    Dosage: unk
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2007-01-01

Gemcitabine Hydrochloride
    Dosage: unk
    Indication: Hodgkin's Disease
    Start date: 2007-01-01

Ifosfamide
    Dosage: unk
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2007-01-01

Ifosfamide
    Dosage: 2 cycles
    Indication: Hodgkin's Disease
    Start date: 2006-01-01

Rituximab
    Dosage: unk
    Indication: Hodgkin's Disease
    Start date: 2007-01-01

Vinblastine
    Dosage: 8 cycles
    Indication: Hodgkin's Disease
    Start date: 2006-01-01

Vinorelbine
    Dosage: unk
    Indication: Hodgkin's Disease
    Start date: 2007-01-01



Possible Bleomycin side effects in 29 year old female

Reported by a physician from Hungary on 2012-08-21

Patient: 29 year old female

Reactions: Histiocytosis Haematophagic, Cytomegalovirus Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Bleomycin
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Carboplatin
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Cisplatin
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Cytarabine
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Dacarbazine
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Dexamethasone
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Doxorubicin HCL
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Doxorubicin HCL

Etoposide
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Etoposide
    Start date: 2007-01-01

Gemcitabine Hydrochloride
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2007-01-01

Ifosfamide
    Start date: 2007-01-01

Ifosfamide
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Rituximab
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2007-01-01

Vinblastine Sulfate
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Vinorelbine
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2007-01-01



Possible Bleomycin side effects in

Reported by a health professional (non-physician/pharmacist) from France on 2012-08-13

Patient:

Reactions: Sepsis, Diffuse Large B-Cell Lymphoma Recurrent, Diffuse Large B-Cell Lymphoma

Adverse event resulted in: death

Drug(s) suspected as cause:
Bleomycin
    Dosage: days 1 and 5
    Indication: Diffuse Large B-Cell Lymphoma

Cyclophosphamide
    Dosage: patients on r-chop received 750 mg/m2 on day 1; and acvbp received 1200 mg/m2
    Indication: Diffuse Large B-Cell Lymphoma

Doxorubicin HCL
    Dosage: day 1,patients on r-chop recieved 50 mg/m2; and on acvbp received 75 mg/m2 on day 1
    Indication: Diffuse Large B-Cell Lymphoma

Prednisone TAB
    Dosage: days 1 through 5
    Indication: Diffuse Large B-Cell Lymphoma

Rituximab
    Dosage: day 1, in r-chop regimen
    Indication: Diffuse Large B-Cell Lymphoma

Vincristine
    Dosage: day 1 in r-chop regimen
    Indication: Diffuse Large B-Cell Lymphoma

Vindesine
    Dosage: days 1 and 5
    Indication: Diffuse Large B-Cell Lymphoma

Other drugs received by patient: Fluorodeoxyglucose F 18



Possible Bleomycin side effects in

Reported by a health professional (non-physician/pharmacist) from France on 2012-08-13

Patient:

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Bleomycin
    Dosage: days 1 and 5
    Indication: Diffuse Large B-Cell Lymphoma

Cyclophosphamide
    Indication: Diffuse Large B-Cell Lymphoma

Cyclophosphamide
    Dosage: day 1

Doxorubicin HCL
    Dosage: day 1
    Indication: Diffuse Large B-Cell Lymphoma

Doxorubicin HCL
    Dosage: day 1

Prednisone TAB
    Dosage: days 1-5
    Indication: Diffuse Large B-Cell Lymphoma

Rituximab
    Dosage: day 1
    Indication: Diffuse Large B-Cell Lymphoma

Vincristine
    Dosage: day 1
    Indication: Diffuse Large B-Cell Lymphoma

Vindesine
    Dosage: days 1 and 5
    Indication: Diffuse Large B-Cell Lymphoma

Other drugs received by patient: Fluorodeoxyglucose F 18



Possible Bleomycin side effects in

Reported by a health professional (non-physician/pharmacist) from France on 2012-08-13

Patient:

Reactions: Diffuse Large B-Cell Lymphoma Recurrent, Myocardial Infarction

Adverse event resulted in: death

Drug(s) suspected as cause:
Bleomycin
    Dosage: on day 1 and 5 in acvbp treatment
    Indication: Diffuse Large B-Cell Lymphoma

Cyclophosphamide
    Dosage: on day 1 in r-chop treatment

Cyclophosphamide
    Dosage: in acvbp treatment
    Indication: Diffuse Large B-Cell Lymphoma

Doxorubicin HCL
    Dosage: r-chop or acvbp treatment
    Indication: Diffuse Large B-Cell Lymphoma

Prednisone TAB
    Dosage: on days 1-5 in r-chop or acvbp treatment
    Indication: Diffuse Large B-Cell Lymphoma

Rituximab
    Dosage: on day 1 in r-chop treatment
    Indication: Diffuse Large B-Cell Lymphoma

Vincristine
    Dosage: on day 1 in r-chop treatment
    Indication: Diffuse Large B-Cell Lymphoma

Vindesine
    Dosage: on day 1 and 5 in acvbp treatment
    Indication: Diffuse Large B-Cell Lymphoma

Other drugs received by patient: Fluorodeoxyglucose F 18



Possible Bleomycin side effects in male

Reported by a physician from Greece on 2012-08-09

Patient: male

Reactions: Pulmonary Toxicity, Dyspnoea, Haemoptysis, Haemorrhage, Pancytopenia, Pyrexia, Bone Marrow Toxicity

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Bleomycin
    Dosage: 30 mg, for 3 days
    Indication: Testis Cancer

Cisplatin
    Dosage: 50 mg/m2, days 1 and 2
    Indication: Testis Cancer

Etoposide
    Dosage: 165 mg/m2, days 1-3
    Indication: Testis Cancer



Possible Bleomycin side effects in 28 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-29

Patient: 28 year old female

Reactions: Streptococcal Bacteraemia, Vomiting, Nausea, Peripheral Sensorimotor Neuropathy, Carbon Monoxide Diffusing Capacity Decreased, Pancytopenia, Febrile Neutropenia, Hypoaesthesia, Paraesthesia, Coordination Abnormal, Gait Disturbance, Renal Failure Acute

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Bleomycin
    Dosage: 15 units/m2 over 24h on day2

Cisplatin
    Dosage: 90 mg/m2 over 4h on day1
    Indication: Ovarian Cancer

Cisplatin
    Dosage: 45 mg/m 2

Cyclophosphamide
    Dosage: 1000 mg/m2 over 60min on day 2
    Indication: Ovarian Cancer

Cyclophosphamide
    Dosage: 750 mg/m 2

Doxorubicin HCL
    Dosage: 45 mg/m2 over 30min on day3
    Indication: Ovarian Cancer

Doxorubicin HCL
    Dosage: 30 mg/m 2

Etoposide
    Dosage: 200 mg/m2 over 2h on day3
    Indication: Ovarian Cancer

Etoposide
    Dosage: 100 mg/m 2

Vinblastine
    Dosage: 6mg/m2 over 30min on day1
    Indication: Ovarian Cancer

Other drugs received by patient: Pegfilgrastim



Possible Bleomycin side effects in 24 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-28

Patient: 24 year old female

Reactions: Mucosal Inflammation, Cellulitis, Pancytopenia

Drug(s) suspected as cause:
Bleomycin
    Dosage: 15 units/m2 over 24 hours on d2
    Indication: Ovarian Cancer

Cisplatin
    Dosage: 90 mg/m2, over 4h on d1
    Indication: Ovarian Cancer

Cyclophosphamide
    Dosage: 1000 mg/m2 over 60 min on d2
    Indication: Ovarian Cancer

Doxorubicin HCL
    Dosage: 45 mg/m2 over 30 min on d3
    Indication: Ovarian Cancer

Etoposide
    Dosage: 200 mg/m2 over 2h on d3
    Indication: Ovarian Cancer

Vinblastine Sulfate
    Dosage: 6 mg/m2 over 30 min on d1
    Indication: Ovarian Cancer

Other drugs received by patient: Pegfilgrastim



Possible Bleomycin side effects in 54 year old male

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-06-21

Patient: 54 year old male

Reactions: Bronchopulmonary Aspergillosis, Neutropenia, Infection

Drug(s) suspected as cause:
Bleomycin
    Dosage: 10 mg/m2, day 8
    Indication: Chemotherapy

Cyclophosphamide
    Dosage: 750 mg/m2, day1
    Indication: Chemotherapy

Doxorubicin HCL
    Dosage: 50 mg/m2, day1
    Indication: Chemotherapy

Etoposide
    Dosage: 200 mg/m2, day1-3
    Indication: Chemotherapy

Prednisolone
    Dosage: 100 mg, day1-14
    Indication: Chemotherapy

Procarbacin
    Dosage: 100 mg/m2, day 1-7

Vincristine
    Dosage: 1.4 mg/m2, day1
    Indication: Chemotherapy



Possible Bleomycin side effects in 35 year old male

Reported by a physician from Israel on 2012-05-29

Patient: 35 year old male

Reactions: Respiratory Disorder

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Bleomycin
    Dosage: 10 mg/m2, for all 6 cycles of beacopp
    Indication: Hodgkin's Disease

Cyclophosphamide
    Dosage: 650 mg/m2for 2 cycles of standard beacopp
    Indication: Hodgkin's Disease

Cyclophosphamide
    Dosage: 1250 mg/m2 for 4 cycles of escalated beacopp

Doxorubicin HCL
    Dosage: 25 mg/m2, m2for 2 cycles of standard beacopp
    Indication: Hodgkin's Disease

Doxorubicin HCL
    Dosage: 35 mg/m2, for 4 cycles of escalated beacopp

Etoposide
    Dosage: 300 mg/m2, for 2 cycles of standard beacopp
    Indication: Hodgkin's Disease

Etoposide
    Dosage: 600 mg/m2, for 4 cycles of escalated beacopp

Prednisone TAB
    Dosage: 280 mg/m2,for all 6 cycles of beacopp
    Indication: Hodgkin's Disease

Procarbazine
    Dosage: 700 mg/m2, for all 6 cycles of beacopp
    Indication: Hodgkin's Disease

Vincristine
    Dosage: 1.4 mg/m2, for all 6 cycles of beacopp
    Indication: Hodgkin's Disease



Possible Bleomycin side effects in 30 year old male

Reported by a physician from Israel on 2012-05-29

Patient: 30 year old male

Reactions: Pulmonary Toxicity, Respiratory Disorder

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Bleomycin
    Dosage: 10 mg/m2,for 6 cycles
    Indication: Hodgkin's Disease

Cyclophosphamide
    Dosage: 650 mg/m2 for 6 cycles
    Indication: Hodgkin's Disease

Doxorubicin HCL
    Dosage: 25 mg/m2 for 6 cycles
    Indication: Hodgkin's Disease

Etoposide
    Dosage: 300 mg/m2,for 6 cycles
    Indication: Hodgkin's Disease

Prednisone TAB
    Dosage: 280 mg/m2 for 6 cycles
    Indication: Hodgkin's Disease

Procarbazine Hydrochloride
    Dosage: 700 mg/m2 for 6 cycles
    Indication: Hodgkin's Disease

Vincristine
    Dosage: 1.4 mg/m2 for 6 cycles
    Indication: Hodgkin's Disease



Possible Bleomycin side effects in 45 year old female

Reported by a physician from Israel on 2012-05-25

Patient: 45 year old female

Reactions: Respiratory Disorder

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Bleomycin
    Dosage: 10 mg/m2, for 6 cycles
    Indication: Hodgkin's Disease

Cyclophosphamide
    Dosage: 650 mg/m2, for 6 cycles
    Indication: Hodgkin's Disease

Doxorubicin HCL
    Dosage: 25 mg/m2, for 6 cycles
    Indication: Hodgkin's Disease

Etoposide
    Dosage: 300 mg/m2, for 6 cycles
    Indication: Hodgkin's Disease

Prednisone TAB
    Dosage: 280 mg/m2, for 6 cycles
    Indication: Hodgkin's Disease

Procarbazine Hydrochloride
    Dosage: 700 mg/m2, for 6 cycles
    Indication: Hodgkin's Disease

Vincristine
    Dosage: 1.4 mg/m2, for 6 cycles
    Indication: Hodgkin's Disease



Possible Bleomycin side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-24

Patient:

Reactions: Vomiting, Nausea, Mental Disorder, Pyrexia, Asthenia, Hepatic Enzyme Increased, Hodgkin's Disease

Drug(s) suspected as cause:
Bleomycin
    Indication: Hodgkin's Disease

Dacarbazine
    Indication: Hodgkin's Disease

Doxorubicin HCL
    Indication: Hodgkin's Disease

Interferon Alfa
    Indication: Hodgkin's Disease

Vinblastine Sulfate
    Indication: Hodgkin's Disease



Possible Bleomycin side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-24

Patient:

Reactions: Pancytopenia

Drug(s) suspected as cause:
Bleomycin
    Dosage: 10u/m2
    Indication: Hodgkin's Disease

Dacarbazine
    Indication: Hodgkin's Disease

Doxorubicin HCL
    Dosage: on day 4
    Indication: Hodgkin's Disease

Interferon Alfa
    Dosage: daily for 3 days prior to chemotherapy and on day 4
    Indication: Hodgkin's Disease

Vinblastine Sulfate
    Indication: Hodgkin's Disease



Possible Bleomycin side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-24

Patient:

Reactions: Hepatotoxicity

Drug(s) suspected as cause:
Bleomycin
    Dosage: 10u/m2
    Indication: Hodgkin's Disease

Dacarbazine
    Indication: Hodgkin's Disease

Doxorubicin HCL
    Dosage: on day 4
    Indication: Hodgkin's Disease

Interferon Alfa
    Dosage: daily for 3 days prior to chemotherapy and on day 4
    Indication: Hodgkin's Disease

Vinblastine Sulfate
    Indication: Hodgkin's Disease



Possible Bleomycin side effects in female

Reported by a health professional (non-physician/pharmacist) from Netherlands on 2012-05-22

Patient: female

Reactions: Premature Menopause

Drug(s) suspected as cause:
Bleomycin
    Indication: Hodgkin's Disease

Dacarbazine
    Indication: Hodgkin's Disease

Doxorubicin Hydrochloride
    Indication: Hodgkin's Disease

Doxorubicin Hydrochloride

Vinblastine Sulfate
    Indication: Hodgkin's Disease



Possible Bleomycin side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-22

Patient:

Reactions: Pulmonary Toxicity

Drug(s) suspected as cause:
Bleomycin
    Dosage: 10u/m2 - cycle 3

Bleomycin
    Dosage: 10u/m2 - cycle 1

Bleomycin
    Dosage: 10u/m2 - cycle 5

Bleomycin
    Dosage: 10u/m2 - cycle 2
    Indication: Hodgkin's Disease

Bleomycin
    Dosage: 10u/m2 - cycle 6

Bleomycin
    Dosage: 10u/m2 - cycle 4

Dacarbazine
    Dosage: cycle 2

Dacarbazine
    Dosage: cycle 6

Dacarbazine
    Dosage: cycle 3

Dacarbazine
    Dosage: cycle 5
    Indication: Hodgkin's Disease

Dacarbazine
    Dosage: cycle 1

Dacarbazine
    Dosage: cycle 4

Doxorubicin Hydrochloride
    Dosage: 1 cycle
    Indication: Hodgkin's Disease

Doxorubicin Hydrochloride
    Dosage: cycle 5

Doxorubicin Hydrochloride
    Dosage: cycle 2

Doxorubicin Hydrochloride
    Dosage: cycle 4

Doxorubicin Hydrochloride
    Dosage: cycle 3

Doxorubicin Hydrochloride
    Dosage: cycle 6

Interferon Alfa
    Indication: Hodgkin's Disease

Interferon Alfa
    Dosage: given day 1-4

Interferon Alfa

Interferon Alfa

Interferon Alfa

Interferon Alfa

Vinblastine Sulfate
    Dosage: cycle 1

Vinblastine Sulfate
    Dosage: cycle 6
    Indication: Hodgkin's Disease

Vinblastine Sulfate
    Dosage: cycle 3

Vinblastine Sulfate
    Dosage: cycle 5

Vinblastine Sulfate
    Dosage: cycle 2

Vinblastine Sulfate
    Dosage: cycle 4



Possible Bleomycin side effects in 33 year old male

Reported by a physician from Israel on 2012-05-21

Patient: 33 year old male

Reactions: Respiratory Disorder

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Bleomycin
    Dosage: 10 mg/m2
    Indication: Hodgkin's Disease

Dacarbazine
    Dosage: 375 mg/m2
    Indication: Hodgkin's Disease

Dexamethasone
    Dosage: 20mg
    Indication: Hodgkin's Disease

Doxorubicin HCL
    Dosage: 25 mg/m2
    Indication: Hodgkin's Disease

Vinblastine Sulfate
    Dosage: 6 g/m2
    Indication: Hodgkin's Disease



Possible Bleomycin side effects in 52 year old male

Reported by a physician from Israel on 2012-05-21

Patient: 52 year old male

Reactions: Pulmonary Toxicity, Respiratory Disorder

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Bleomycin
    Dosage: 10 mg/m2
    Indication: Hodgkin's Disease

Dacarbazine
    Dosage: 375 mg/m2
    Indication: Hodgkin's Disease

Dexamethasone
    Dosage: 20mg
    Indication: Hodgkin's Disease

Doxorubicin HCL
    Dosage: 25 mg/m2
    Indication: Hodgkin's Disease

Vinblastine Sulfate
    Dosage: 6 g/m2
    Indication: Hodgkin's Disease



Possible Bleomycin side effects in 45 year old female

Reported by a physician from Israel on 2012-05-21

Patient: 45 year old female

Reactions: Respiratory Disorder

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Bleomycin
    Dosage: 10 mg/m2 for 6 cycles
    Indication: Hodgkin's Disease

Cytoxan
    Dosage: 650 mg/m2 for 6 cycles
    Indication: Hodgkin's Disease

Doxorubicin HCL
    Dosage: 25 mg/m2 for 6 cycles
    Indication: Hodgkin's Disease

Etoposide
    Dosage: 300 mg/m2 for 6 cycles
    Indication: Hodgkin's Disease

Prednisone
    Dosage: 280 mg/m2 for 6 cycles
    Indication: Hodgkin's Disease

Procarbazine Hydrochloride
    Dosage: 700 mg/m2 for 6 cycles
    Indication: Hodgkin's Disease

Vincristine
    Dosage: 1.4 mg/m2 for 6 cycles
    Indication: Hodgkin's Disease



Possible Bleomycin side effects in 26 year old female

Reported by a physician from Israel on 2012-05-21

Patient: 26 year old female

Reactions: Respiratory Disorder

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Bleomycin
    Dosage: 10 mg/m2
    Indication: Hodgkin's Disease

Dacarbazine
    Dosage: 375 mg/m2
    Indication: Hodgkin's Disease

Dexamethasone
    Dosage: 20mg
    Indication: Hodgkin's Disease

Doxorubicin HCL
    Dosage: 25 mg/m2
    Indication: Hodgkin's Disease

Vinblastine Sulfate
    Dosage: 6 g/m2
    Indication: Hodgkin's Disease



Possible Bleomycin side effects in 30 year old male

Reported by a physician from Israel on 2012-05-21

Patient: 30 year old male

Reactions: Pulmonary Toxicity, Respiratory Disorder

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Bleomycin
    Dosage: 10 mg/m2 for 6 cycles
    Indication: Hodgkin's Disease

Cytoxan
    Dosage: 650 mg/m2 for 6 cycles
    Indication: Hodgkin's Disease

Doxorubicin HCL
    Dosage: 25 mg/m2 for 6 cycles
    Indication: Hodgkin's Disease

Etoposide
    Dosage: 300 mg/m2 for 6 cycles
    Indication: Hodgkin's Disease

Prednisone
    Dosage: 280 mg/m2 for 6 cycles
    Indication: Hodgkin's Disease

Procarbazine Hydrochloride
    Dosage: 700 mg/m2 for 6 cycles
    Indication: Hodgkin's Disease

Vincristine
    Dosage: 1.4 mg/m2 for 6 cycles
    Indication: Hodgkin's Disease



Possible Bleomycin side effects in male

Reported by a physician from United States on 2012-05-16

Patient: male, weighing 73.8 kg (162.4 pounds)

Reactions: Lung Disorder, Pneumonitis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Bleomycin
    Dosage: 152 unit

Dacarbazine
    Dosage: 5746 mg

Doxorubicin Hydrochloride
    Dosage: 384 mg

Vinblastine Sulfate
    Dosage: 94 mg



Possible Bleomycin side effects in 42 year old male

Reported by a physician from Croatia (Local Name: Hrvatska) on 2012-05-14

Patient: 42 year old male, weighing 87.0 kg (191.4 pounds)

Reactions: Throat Irritation, Thrombocytopenia, Leukopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Bleomycin
    Dosage: 30 mg, unk
    Indication: Testis Cancer
    Start date: 2012-01-14
    End date: 2012-01-18

Cisplatin
    Dosage: 42 mg, unk
    Indication: Testis Cancer
    Start date: 2012-01-14
    End date: 2012-01-18

Etoposide
    Dosage: 210 mg, unk
    Indication: Testis Cancer
    Start date: 2012-01-14
    End date: 2012-01-18



Possible Bleomycin side effects in

Reported by a physician from Italy on 2012-05-04

Patient:

Reactions: Death, Hodgkin's Disease Recurrent, Lung Disorder, Pulmonary Embolism, Treatment Failure, Lymphoma, Hodgkin's Disease

Adverse event resulted in: death

Drug(s) suspected as cause:
Bleomycin
    Indication: Hodgkin's Disease

Dacarbazine
    Indication: Hodgkin's Disease

Doxorubicin HCL
    Indication: Hodgkin's Disease

Doxorubicin HCL

Epirubicin Hydrochloride
    Indication: Hodgkin's Disease

Etoposide
    Indication: Hodgkin's Disease

Lomustine
    Indication: Hodgkin's Disease

Mechlorethamine
    Indication: Hodgkin's Disease

Prednisone TAB
    Indication: Hodgkin's Disease

Procarbazine Hydrochloride
    Indication: Hodgkin's Disease

Vinblastine
    Indication: Hodgkin's Disease

Vincristine Sulfate
    Indication: Hodgkin's Disease

Vindesine
    Indication: Hodgkin's Disease



Possible Bleomycin side effects in 42 year old male

Reported by a physician from Croatia (Local Name: Hrvatska) on 2012-05-03

Patient: 42 year old male, weighing 87.0 kg (191.4 pounds)

Reactions: Throat Irritation, Thrombocytopenia, Leukopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Bleomycin
    Dosage: 30 mg, unk
    Indication: Testis Cancer
    Start date: 2012-01-14
    End date: 2012-01-18

Cisplatin
    Dosage: 42 mg, unk
    Indication: Testis Cancer
    Start date: 2012-01-14
    End date: 2012-01-18

Etoposide
    Dosage: 210 mg, unk
    Indication: Testis Cancer
    Start date: 2012-01-14
    End date: 2012-01-18



Possible Bleomycin side effects in 50 year old male

Reported by a physician from Greece on 2012-05-02

Patient: 50 year old male

Reactions: Multi-Organ Failure, Toxicity To Various Agents

Adverse event resulted in: death

Drug(s) suspected as cause:
Bleomycin
    Indication: Hodgkin's Disease

Dacarbazine
    Indication: Hodgkin's Disease

Doxorubicin HCL
    Indication: Hodgkin's Disease

Etoposide
    Indication: Hodgkin's Disease

Ifosfamide
    Indication: Hodgkin's Disease

Mesna
    Indication: Hodgkin's Disease

Mitoxantrone Hydrochloride

Vinblastine
    Indication: Hodgkin's Disease



Possible Bleomycin side effects in 69 year old male

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-02-23

Patient: 69 year old male

Reactions: Gastrointestinal Haemorrhage, Blood Creatinine Increased

Drug(s) suspected as cause:
Bleomycin
    Dosage: 30000 iu, day 2
    Indication: Testicular Germ Cell Cancer

Carboplatin
    Indication: Testicular Germ Cell Cancer

Cisplatin
    Dosage: 100 mg/m2, cyclic
    Indication: Testicular Germ Cell Cancer

Etoposide
    Dosage: 500 mg/m2, cyclic
    Indication: Testicular Germ Cell Cancer



Possible Bleomycin side effects in 69 year old male

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-02-21

Patient: 69 year old male

Reactions: Gastrointestinal Haemorrhage, Blood Creatinine Increased

Drug(s) suspected as cause:
Bleomycin

Carboplatin
    Indication: Testicular Germ Cell Cancer

Cisplatin

Etoposide



Possible Bleomycin side effects in 27 year old male

Reported by a physician from Portugal on 2012-02-15

Patient: 27 year old male

Reactions: Bronchopulmonary Aspergillosis, Lymphopenia, Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Bleomycin
    Indication: Testis Cancer

Cisplatin
    Dosage: 1st-line: cycles every 21d, 2nd-line: cycles every 28d
    Indication: Testis Cancer

Etoposide
    Indication: Testis Cancer

Ifosfamide
    Indication: Testis Cancer

Vinblastine Sulfate
    Indication: Testis Cancer

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012